UNSPSC 51295106: Clodazon hydrochloride anhydrous

This classification denotes an antidepressant agent C18H20ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N0FW29BP3C, chemically known as 2h-benzimidazol-2-one,5-chloro-1-(3-(dimethylamino)propyl)-1,3-dihydro-3-phenyl-, monohydrochloride, but more generally known as clodazon hydrochloride anhydrous, which bears US NIH Compound Identifier 56841979. Most nations, for tariff and trade purposes, schedule clodazon hydrochloride anhydrous under HS 29339990 and SITC 51577.

As of Q4 2014, CLODAZON HYDROCHLORIDE ANHYDROUS remains US FDA's Preferred Term for this commodity. Clodazon hydrochloride anhydrous bears US NLM identifiers UMLS ID C2699361 and NCI Concept Code C78675. SMILES: CN(C)CCCN1C2CCC(CC2N(C1=O)C3CCCCC3)CL.CL.

UNSPSC 51295106 Clodazon hydrochloride anhydrous is a Commodity code that nominally covers a specific pharmaceutical active ingredient, but recent state and local solicitations using this code show minimal direct relevance to clodazon itself. Instead, the code appears to be tagged on broader pharmaceutical procurement activities including naloxone supply, generic multi-source pharmaceuticals, and over-the-counter product distribution. State and local governments are soliciting under this code for pharmaceutical supply contracts that span community health initiatives, pharmacy benefit programs, and cooperative purchasing arrangements across multiple jurisdictions. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). These entities are seeking vendors capable of providing pharmaceutical inventory, managing wholesaler relationships, complying with FDA and Drug Supply Chain Security Act requirements, and delivering products on fixed or negotiated net pricing models.

Recent activity shows Seminole County, Florida issued an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly delivery to Sanford, Florida, due July 26, 2023. The Texas HHS Commission posted an RFI (HHS0017013) in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (Solicitation Number S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. Activity spans Florida, Texas, and the upper Midwest, with MMCAP representing a multistate vehicle that widens geographic reach. Vendors responding to opportunities in this code category must maintain multiple wholesaler relationships, achieve cGMP certification, comply with federal drug supply chain regulations, and offer flexible pricing models; the code itself shows limited direct procurement of clodazon hydrochloride anhydrous as a line item.